Global /Norway /Healthcare /Biotechnology /CRNA

Circio Holding ASA

CRNA

• OSL: CRNA • Delayed

9.55NOK 5%

1.02 USD

As of 5 June 2026, Circio Holding ASA has a market cap of $232.4M USD, ranking #20144 globally and #114 in Norway. It ranks #1811 in the Healthcare sector, and #349 in the Biotechnology industry.

Global Rank

20144

Country Rank

114

Sector Rank

1811

Industry Rank

349

Key Stats

Market Cap

$232.4MUSD

2.17B NOK

Enterprise Value

$232.05MUSD

2.17B NOK

EBITDA (TTM)

-$4.39MUSD

-41.03M NOK

Net Income (TTM)

-$4.92MUSD

-45.91M NOK

PB Ratio

-173.4

Company Profile

Country (HQ)

Norway

Sector

Healthcare

Industry

Biotechnology

CEO

Erik Wiklund open_in_new

Employees

Founded

2010

Website

circio.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
5%	1.1%	11%	760%	912%	682%	1K%	-48%	-96%

News

Markets

Exchange	Ticker	Price	Quotes
Euronext Oslo Børs (OSL) MIC: XOSL PRIMARY	CRNA ISIN: NO0013033795 Shares Out.: Shares Outstanding: 238.172M¹ Shares Float: 204.536M² TV: TradingView: OSL: CRNA SA: Stock Analysis: OSL: CRNA YF: Yahoo Finance: CRNA.OL GF: Google Finance: OSL: CRNA BA: Barron's: CRNA MS: Morningstar: XOSL: CRNA	9.55 NOK	TV: TradingView: OSL: CRNA SA: Stock Analysis: OSL: CRNA YF: Yahoo Finance: CRNA.OL GF: Google Finance: OSL: CRNA BA: Barron's: CRNA MS: Morningstar: XOSL: CRNA
London Stock Exchange (LSE / LON) MIC: XLON	0RIS ISIN: NO0013033795 TV: TradingView: LSE: 0RIS SA: Stock Analysis: LON: 0RIS YF: Yahoo Finance: 0RIS.L GF: Google Finance: LON: 0RIS BA: Barron's: 0RIS MS: Morningstar: XLON: 0RIS	8.53 NOK	TV: TradingView: LSE: 0RIS SA: Stock Analysis: LON: 0RIS YF: Yahoo Finance: 0RIS.L GF: Google Finance: LON: 0RIS BA: Barron's: 0RIS MS: Morningstar: XLON: 0RIS
Nasdaq Stockholm (STO) MIC: XSTO	TRVXO (CRNAO) ISIN: NO0013033795 TV: TradingView: OMXSTO: TRVXO SA: Stock Analysis: STO: TRVXO YF: Yahoo Finance: TRVXO.ST GF: Google Finance: STO: TRVXO BA: Barron's: TRVXO MS: Morningstar: XSTO: TRVXO	8.45 NOK	TV: TradingView: OMXSTO: TRVXO SA: Stock Analysis: STO: TRVXO YF: Yahoo Finance: TRVXO.ST GF: Google Finance: STO: TRVXO BA: Barron's: TRVXO MS: Morningstar: XSTO: TRVXO

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Circio Holding ASA

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a collaboration with Certest Biotec, S.L. for formulation of circVec. The company has a research collaboration with United Immunity Co., Ltd. for the development of vivo CAR-Macrophage (CAR-M) therapy. The company was formerly known as Targovax ASA and changed its name to Circio Holding ASA in May 2023. The company was incorporated in 2010 and is based in Oslo, Norway.

Similar Companies

Industry: Biotechnology (Norway)

Name	Market Cap (USD) diff.	PE	Country
Zelluna ASA OSL: ZLNA	$66.23M 617.34M NOK -72%	-	Norway
EXACT Therapeutics AS OSL: EXTX	$9.91M 92.36M NOK -96%	-	Norway
BerGenBio ASA OSL: BGBIO	$4.91M 45.73M NOK -98%	-	Norway

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 78K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 69K%	19.0	United States
argenx SE EBR: ARGX	$48.01B 41.39B EUR 21K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.36B 68.19T KRW 19K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.98B 60.27B AUD 18K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.55B 33.71B CHF 18K%	37.2	Switzerland

chevron_leftBack